Delivery Order SPE2DB22D2007-SPE2DB26FH6MM
- Not listed
- The Defense Logistics Agency awarded a $3,541.53 delivery order to AmerisourceBergen Drug Corp for Azelastine 0.1% (137 MCG) spray in 30ML quantities. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 7, 2025, and represents a child order under the vendor's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a $87 firm fixed price delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will supply 4561911878 units of the 0.1% 137 mcg spray to the DLA under a one-day period of performance ending August 24, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the contract from its facilities in Conshohocken, Pennsylvania. The delivery order was issued...
- The Defense Logistics Agency Troop Support Medical awarded a $522,720 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561942774 AZELASTINE 0.1% (137 MCG) SPRY 30ML. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 25-28, 2023. This delivery order was issued against an existing indefinite-delivery/indefinite-quantity contract vehicle held by Amerisourcebergen, though further...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Azelastine HCL 0.05% ophthalmic drops (6ml units) with a ceiling value of $1,809.36. This non-competitive, firm fixed-price delivery order was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025. The product will be delivered from AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $261 delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will supply approximately 137 micrograms of the nasal spray packaged in 30ml bottles to fulfill DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period from August 29 to 30, 2023. The firm fixed price contract was awarded utilizing...
- The Defense Logistics Agency awarded a $72,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will supply approximately 137 milligrams of the nasal spray to meet Defense Logistics Agency requirements under the delivery order. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period in early August 2023. No subcontractors or set aside...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,042.50 order is for the supply of 4564083835 - AZELASTINE 0.1% (137 MCG) SPRY 30ML, a pharmaceutical product, with a performance period ending on March 27, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of...
- The Defense Logistics Agency awarded a $261 delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As part of DLA's medical supply chain support to the Department of Defense, this firm fixed price order calls for delivery of 137 microgram sprays in 30 milliliter bottles from Amerisourcebergen's facility in Conshohocken, Pennsylvania. The parent company, Amerisourcebergen Corporation, will perform through its corporate office division. No subcontractors...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at one hundred eighty-two dollars to Amerisourcebergen Drug Corporation for the supply of azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will deliver 4561978888 units of the 0.1% 137 mcg spray to a location in Conshohocken, Pennsylvania, with performance required between August 29 and 30, 2023. The ordering activity and funding for this contract action comes from the Defense...
- The Defense Logistics Agency (DLA) awarded a $1,509.88 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4563337141 ! AZELASTINE 0.1% (137 MCG) SPRY 30ML. This order was placed under a larger contract held by Amerisourcebergen with the DLA Troop Support Medical program to provide pharmaceuticals and medical supplies. The performance location is Amerisourcebergen's corporate office in Conshohocken, Pennsylvania. No set-aside...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB26FH6MMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,991.28 to AmerisourceBergen Drug Corp for Azelastine 0.1% (137 mcg) spray in 30 mL quantities. This non-set-aside, firm fixed-price delivery order was awarded on October 27, 2025, with completion anticipated by October 28, 2025. The pharmaceutical will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This award represents a child contract under a larger indefinite delivery contract vehicle. This delivery order falls under AmerisourceBergen's comprehensive Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999.99 million through December 2026. The parent contract serves as a global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal medical systems worldwide. AmerisourceBergen's extensive contract portfolio with DLA demonstrates its critical role as a pharmaceutical distributor within the federal medical supply chain, serving the Defense Health Agency, U.S. Coast Guard, and related government healthcare organizations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 10/27/25 |